CCL5 and atherosclerosis: There is a lot of evidence that the blood plasma of patients with atherosclerosis is enriched in activation molecules, including chemokines which can drive CTL migration, e.g., CCL5, CCL4, CCL3, CX3CL1 (28, 29).